Cellyan Biotechnology (HKPD) vs Herbalife (HLF)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
Herbalife is the larger company by market cap ($1.35 billion vs $5.5 million), about 244.6 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | HKPD | HLF |
|---|---|---|
| Share price | $0.112 | $13.03 |
| Market cap | $5.52M | $1.35B |
| 1-day change | +11.11% | +1.64% |
| YTD return | — | +1.09% |
| 1-year return | — | +44.46% |
| 5-year return | — | -70.04% |
| P/E ratio (TTM) | — | 8.14 |
| Forward P/E | — | 4.23 |
| EPS (TTM) | $-0.08 | $1.60 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $1.72 | $20.40 |
| 52-week low | $0.095 | $7.56 |
| Distance from 52-week high | -93.48% | -36.13% |
| Analyst consensus | — | none |
| Avg. price target upside | — | +30.47% |
| Average volume | 3.84M | 1.55M |
| Shares outstanding | 42.17M | 103.67M |
| Employees | 11 | 8,500 |
| Sector | Health Care | Health Care |
| Industry | Other Pharmaceuticals | Other Pharmaceuticals |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Herbalife is about 244.6 times larger than Cellyan Biotechnology by market value ($1.35B vs $5.52M).
About Cellyan Biotechnology
HKPD stock →Cellyan Biotechnology Co., Ltd, an investment holding company, engages in the over-the counter (OTC) pharmaceutical business in Hong Kong and Mainland China. The company provides OTC pharmaceutical cross-border procurement and distribution and e-commerce supply chain services.
Health Care · Other Pharmaceuticals · 11 employees
About Herbalife
HLF stock →Herbalife Ltd., together with its subsidiaries, provides health and wellness products in North America, Mexico, South and Central America, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers weight management products, including meal replacement, protein shakes, drink mixes, weight loss supplements, healthy snacks, and metabolism boosting teas; targeted nutrition products comprising functional beverages and dietary and nutritional supplements containing herbs, vitamins, minerals and other natural ingredients; energy, sports, and fitness products; and facial skin care, body care, and hair care products.
Health Care · Other Pharmaceuticals · 8,500 employees
HKPD vs HLF FAQ
Which is bigger, Cellyan Biotechnology or Herbalife?
Herbalife (HLF) is larger, with a market capitalization of $1.35B compared with $5.52M for Cellyan Biotechnology (HKPD).
Are Cellyan Biotechnology and Herbalife in the same industry?
Yes. Both are classified in the Other Pharmaceuticals industry within the Health Care sector.